Pfizer, the world’s biggest pharmaceutical group, is willing to acquire a large rival drugs company to improve its financial health, in a move that could trigger a fresh round of mergers within the sector.

Jeff Kindler, chief executive, said: “The real goal is to grow revenues . . . We are open to opportunities and constantly looking at those which are big, small and inbetween.”